Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzania
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to assess the effectiveness of artemether-lumefantrine
(Coartem®) treatment provided by community health workers against uncomplicated malaria in
children under 5 years of age in Kibaha District, Tanzania, during an extended follow-up of
42 days. The hypothesis is that artemether-lumefantrine treatment provided by community
health workers will result in less than 85% PCR-corrected parasitological effectiveness by
day 42, mainly due to partial non-compliance to full standard 6-dose regimen of the drug.
Phase:
Phase 4
Details
Lead Sponsor:
Karolinska University Hospital
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Lumefantrine